Maternal oxytocin mitigates offspring autism-like phenotypes and oxytocin system alterations through improved maternal care.

Publication date: Jul 08, 2026

Maternal care is crucial for normal neurodevelopment. Disruptions in early caregiver-infant interactions, potentially linked to modern lifestyles, may contribute to the rising prevalence of neurodevelopmental disorders such as Autism Spectrum Disorder (ASD). Given the reported deficits in the oxytocinergic system in both ASD and impaired mother-child interactions, this study investigated: (1) whether inadequate maternal care induced by early-life maternal separation (MS) in female rats leads to autism-like phenotypes in their offspring, and (2) whether improving maternal care with oxytocin (OXT) can ameliorate these outcomes. Female rat pups underwent MS (3 h/day from postnatal day (PND) 1-14). As adults, they were mated and assigned to MS+Saline, MS + OXT (0. 8 IU/kg intranasal, PND1-14), or control groups. Maternal behavior was assessed. Their male offspring were evaluated during adolescence for social and repetitive behaviors, and their brains were analyzed for hypothalamic OXT and hippocampal Oxytocin Receptors (OXTRs) expression. Dams with a MS history exhibited impaired maternal care, characterized by reduced nursing and increased harmful behaviors. OXT treatment significantly improved maternal care in these dams. The offspring of MS+Saline dams displayed core autism-like phenotypes, including social deficits and increased repetitive behaviors, alongside reduced OXT expression in the hypothalamus and OXTR expression in the hippocampus. Crucially, these behavioral and neurobiological abnormalities were ameliorated in the offspring of OXT-treated MS dams. This study demonstrates that impaired maternal care, resulting from early-life stress, can induce autism-like abnormalities in offspring. OXT administration to dams effectively improves maternal behavior and mitigates the development of these abnormalities, highlighting the maternal environment as a key modifiable factor. Our findings provide a compelling preclinical framework supporting the potential of early interventions focused on the parent-child environment to mitigate neurodevelopmental risk.

Open Access PDF

Concepts Keywords
Autism Autism
Caregiver Early life adversities
Increased Maternal care
Neurobiological Oxytocin
Postnatal Oxytocin Receptor
Rat

Semantics

Type Source Name
drug DRUGBANK Oxytocin
disease MESH autism
disease MESH neurodevelopmental disorders
disease MESH Autism Spectrum Disorder
pathway REACTOME Reproduction
disease MESH included
drug DRUGBANK Coenzyme M
disease MESH genetic disorder
drug DRUGBANK Water
disease MESH MS+Saline
drug DRUGBANK Ethanol
disease MESH glass
drug DRUGBANK Ketamine
drug DRUGBANK Heparin
drug DRUGBANK Phosphate ion
drug DRUGBANK Gelatin
disease MESH image
disease MESH PBS
drug DRUGBANK Glycerin
disease MESH IBM
drug DRUGBANK Proline
disease MESH anxiety
drug DRUGBANK Corticotropin
drug DRUGBANK Corticosterone
disease MESH dissociation
disease MESH pmc
drug DRUGBANK Guanosine
disease MESH Trauma
disease MESH cognitive impairments
drug DRUGBANK Hydrocortisone
drug DRUGBANK Serotonin
drug DRUGBANK D-Alanine
disease MESH Metabolic Brain Disease
drug DRUGBANK Dopamine
drug DRUGBANK Vasopressin
drug DRUGBANK Diethylstilbestrol
disease MESH Des
drug DRUGBANK Nandrolone phenpropionate
disease MESH COVID 19 Pandemic

Original Article

(Visited 49 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *